Shockwave Medical’s Investigator-Sponsored Research (ISR) Program is committed to supporting external research focused on calcified arterial disease and refractory angina.
ISR Portal
All submissions and communications are conducted through the ISR portal
Steps to Submit a Research Proposal:
-
Create and validate a portal account
-
Title the submission and agree to the attestation statement
-
Complete submission form
-
Upload CV (required) and other supporting documents (optional)
-
Information can be saved and returned to as needed
ISR Program Overview
Shockwave Medical provides financial and/or product support for independent research activity. Our global research program is open to all investigators qualified to conduct clinical or pre-clinical research.
After submission, a proposal undergoes initial review; only clear and complete proposals will progress to a monthly committee review, where proposals are considered according to the following factors:
-
Whether the research furthers Shockwave Medical’s mission
-
Overlap with ongoing/planned research
-
Scientific rigor and quality of proposal
-
Likelihood of generating novel and meaningful information
-
Appropriate size and scope of the study
-
Fair market value
-
Qualifications and capabilities of the investigator
-
Compliance with regulatory requirements
-
Any other criteria deemed appropriate
If funding is approved, a research agreement is negotiated between the research sponsor and Shockwave Medical, containing the final budget and research protocol. Investigators are expected to provide regular updates on study progress and to share their findings via conference presentations and in peer-reviewed journals.
Responsibilities of the Investigator and Shockwave Medical
The study sponsor and the principal investigator have full and final discretion and responsibility for all
aspects
of the study including:
-
Study design and protocol authorship
-
Study operation
-
Data collection, storage and analysis
-
Authorship of all publication activity
-
Compliance with all laws and regulations applicable to research sponsors
Shockwave Medical will provide financial and/or product support as agreed upon by both parties in a written ISR
Research Agreement.
-
Shockwave Medical will not provide operational support; this is the responsibility of the
sponsor-investigator
-
Shockwave Medical will offer guidance and feedback throughout research activities
Approval Process
Upon submission, a proposal undergoes an initial review. Only clear and complete proposals will progress to a
monthly committee review. During evaluation, the following factors are considered:
-
Whether the research furthers Shockwave Medical’s mission or provides novel information (diagnostic,
treatment
or disease areas) of interest to Shockwave Medical
-
Potential overlap with ongoing/planned research activities
-
Scientific rigor and quality of research proposal
-
Likelihood to produce novel and meaningful information
-
Appropriate size and scope for the study
-
Fair market value
-
Investigator qualifications, expertise and prior research performance
-
Compliance with regulatory requirements regarding unapproved devices or uses
-
Any other criteria deemed appropriate
The review committee may directly approve projects that meet the evaluation criteria outlined above.
Alternatively, the committee may suggest minor changes to improve the scientific merit of the research or
directly decline projects that do not meet the criteria. Shockwave Medical provides no guarantees to provide
support for your proposal.
What to Expect Once Approved
Research Agreement: If funding is approved, a research agreement is coordinated between Shockwave
Medical
and the investigator’s institution. The research agreement protects physicians, patients and Shockwave Medical
by
defining roles and expectations. It addresses issues such as understanding the requirements of a
sponsor-investigator, intellectual property ownership and publication.
To execute a research agreement, Shockwave Medical and the sponsoring institution negotiate:
-
The various clauses of the research agreement legal contract
-
Time period for Shockwave Medical review of final study results prior to publication
-
Details of the final study protocol
-
Progress-based milestones for financial and/or product support
Investigator Communication: Investigators are expected to provide regular study updates to Shockwave
Medical
throughout the active stages of research. The following periodic updates are required:
-
Register the trial on a clinical trials registry (e.g., clinicaltrials.gov)
-
Monthly total number of patients enrolled and devices used
-
Quarterly predictions for milestone achievement dates
-
Actual milestone achievement dates
Financial/Product Support: Shockwave Medical and the study sponsor negotiate the size and distribution
of study support to ensure funding throughout the study lifecycle and encourage continued progress. After
confirming achievement of a milestone, Shockwave Medical will pay the agreed upon amount within 30 days of
receiving an invoice.
Publication Activity: Conference presentations and peer-reviewed publications are the ultimate goals of
a successful research project. This activity benefits patients and society, as well as the wider research
community.
-
Investigators should coordinate with Shockwave Medical their plan for conference presentation and
peer-reviewed publishing
-
Shockwave Medical has the right to review summary results (e.g., abstract, draft manuscript, etc.)
before public disclosure
-
No Shockwave Medical employees will be an author on your publication
-
Investigators should post results of the study on a clinical trial registry (e.g., clinicaltrials.gov)
-
Ask a Question
If you have questions, please reach out to Shockwave Medical
Affairs.
Contact Us